StockData
Enovis CORP logo

Enovis CORP (ENOV) stock

ENOVNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jul 3, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3066% below fair value
$27.10−0.12 (-0.44%)

Close on Nov 18, 2026Market cap $1.56BP/E –Yield –

Enovis cash

Cash and short-term investments held at the end of each period.

Enovis's cash was $12.56M at Jul 3, 2026. For fiscal 2025 it was $36.39M, down 24.5% from the year before. Over ten years it grew -15.6% a year on average. The highest annual figure on record is $680.25M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$36.39M-24.5%
FY2024Dec 31, 2024$48.17M+33.1%
FY2023Dec 31, 2023$36.19M+49.0%
FY2022Dec 31, 2022$24.30M-96.4%
FY2021Dec 31, 2021$680.25M+600.8%
FY2020Dec 31, 2020$97.07M-11.5%
FY2019Dec 31, 2019$109.63M+42.1%
FY2018Dec 31, 2018$77.15M-81.3%
FY2017Dec 31, 2017$411.63M+97.1%
FY2016Dec 31, 2016$208.81M+5.7%
FY2015Dec 31, 2015$197.47M-35.4%
FY2014Dec 31, 2014$305.45M-1.9%
FY2013Dec 31, 2013$311.30M-35.5%
FY2012Dec 31, 2012$482.45M+542.3%
FY2011Dec 31, 2011$75.11M+24.1%
FY2010Dec 31, 2010$60.54M+21.2%
FY2009Dec 31, 2009$49.96M+73.7%
FY2008Dec 31, 2008$28.76M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jul 3, 2026$12.56M-71.5%
Q1 FY2026Apr 3, 2026$33.13M-13.9%
Q4 FY2025Dec 31, 2025$36.39M-24.5%
Q3 FY2025Oct 3, 2025$33.62M-5.1%
Q2 FY2025Jul 4, 2025$44.07M+25.9%
Q1 FY2025Apr 4, 2025$38.46M-42.0%
Q4 FY2024Dec 31, 2024$48.17M+33.1%
Q3 FY2024Sep 27, 2024$35.43M+10.3%
Q2 FY2024Jun 28, 2024$35.00M+7.7%
Q1 FY2024Mar 29, 2024$66.27M+202.6%
Q4 FY2023Dec 31, 2023$36.19M+49.0%
Q3 FY2023Sep 29, 2023$32.13M-41.5%
Q2 FY2023Jun 30, 2023$32.49M-66.0%
Q1 FY2023Mar 31, 2023$21.90M-96.7%
Q4 FY2022Dec 31, 2022$24.30M-96.4%
Q3 FY2022Sep 30, 2022$54.96M-69.0%
Q2 FY2022Jul 1, 2022$95.61M+53.4%
Q1 FY2022Apr 1, 2022$661.50M-13.4%
Q4 FY2021Dec 31, 2021$680.25M+600.8%
Q3 FY2021Oct 1, 2021$177.48M+167.2%
Q2 FY2021Jul 2, 2021$62.31M-6.2%
Q1 FY2021Apr 2, 2021$763.65M+108.9%
Q4 FY2020Dec 31, 2020$97.07M-11.5%
Q3 FY2020Oct 2, 2020$66.42M-47.7%
Q2 FY2020Jul 3, 2020$66.40M-49.7%
Q1 FY2020Apr 3, 2020$365.60M+50.8%
Q4 FY2019Dec 31, 2019$109.63M+42.1%
Q3 FY2019Sep 27, 2019$127.07M-55.6%
Q2 FY2019Jun 28, 2019$131.93M-48.8%
Q1 FY2019Mar 29, 2019$242.42M-39.9%
Q4 FY2018Dec 31, 2018$77.15M-81.3%
Q3 FY2018Sep 28, 2018$285.90M+9.8%
Q2 FY2018Jun 29, 2018$257.70M-5.3%
Q1 FY2018Mar 31, 2018$403.24M+94.0%
Q4 FY2017Dec 31, 2017$411.63M+97.1%
Q3 FY2017Sep 29, 2017$260.41M+35.9%
Q2 FY2017Jun 30, 2017$272.23M–
Q1 FY2017Mar 31, 2017$207.84M–
Q4 FY2016Dec 31, 2016$208.81M–
Q3 FY2016Sep 30, 2016$191.66M–

More Enovis figures

See a number that looks wrong?